Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2012.131 | Psychiatric Morbidity in Adult Patients with Cervical Dysplasia in a Colposcopy Clinica in Hong Kong | Dr. YAN Connie Tin Yee |
| 2018.045 | The Prevalence of Frontotemporal Lobar Degeneration in Patients attending Psychogeriatric Services in a Local Tertiary Hospital in Hong Kong |
Dr. YAN Connie Tin Yee 甄天懿 |
| 2018.632 | Comparison of the Wilson Sims Fall Risk Assessment Tool and Morse Fall Scale | Dr. YAN Connie Tin Yee |
| 2020.431 | Barriers and facilitators to the implementation of telemedicine-based, real-time, online consultation among family physicians working in the public sector. | Dr. YAN Chi Yung |
| 2012.086 | A Novel Pharmacological Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease: A Randomized Double-blind Placebo-control Trial of Traditional Chinese Medicine Salviae miltiorhizae(Danshen) and Puerariae lobatae (Gegen) | Professor Yan Bryan Ping-Yen |
| 2016.687 | The effects of a modelling-based narrative intervention on care-seeking behavioural intention and prehospital care-seeking delay in patients with acute myocardial infarction | Prof. YAN Bryan Ping-Yen |
| 2020.332 | A Randomised, Double-Blind, Phase 1b/2a, Placebo-Controlled, Single Dose Study to Evaluate Safety, Tolerability, and Efficacy of YQ23 in Adult Patients with Critical Limb Ischaemia |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.181 | Description of evolocumab use among adults with established atherosclerotic cardiovascular disease or hypercholesterolemia in Asia-Pacific region – an observational study of clinical practice |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.459 | BioFreedom Ultra Stent in Hong Kong All Comers Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.717 | In-hospital initiation of empagliflozin for the treatment of new-onset acute heart failure regardless of ejection fraction: A Pilot Study |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.287 | Validation of a novel device for screening patients with atrial fibrillation / arrhythmia | Prof. YAN Bryan Ping Yen |
| 2023.296 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK‑0616 in Adults With Heterozygous Familial Hypercholesterolemia |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.400 | LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS treatment-Below The Knee) Randomized Controlled Trial |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.409 | Validation of Pulse Sensors for Cardiovascular Disease Management |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.497 | In-hospital initiation of Angiotensin–Neprilysin Inhibition for the treatment of acute heart failure regardless of ejection fraction: An open labelled randomized study | Prof. YAN Bryan Ping Yen |
| 2023.186 | Investigation of the adverse effects of antiviral compounds |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.457 | Develop multi-modal spectroscopy (MMS) & biosensor platforms for monitoring cardiovascular diseases (CVDs) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.718 | The effects and cost-effectiveness of a technology-based family-centered empowerment (T-FAME) program on health and health service utilization outcomes of post-discharged patients with advanced heart failure: A sequential mixed method study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.316 | A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR™ 018 Drug Eluting Balloon in the Treatment of Subjects With Femoropopliteal Artery Lesions |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.449 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.464 | Time-trend analysis of clinical characteristic and outcomes in patients with unprotected left main coronary artery disease treated with PCI over a 10-year period from year 2010 till year 2020. | Prof. YAN Bryan Ping Yen |
| 2022.038 | Prevalence of LVEF non-recovery after acute myocardial Infarction |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.041 | A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high-risk primary prevention patients (VICTORION-1 PREVENT) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.637 | Drug-Coated Balloon for the Treatment of De Novo and Restenotic Coronary Artery Lesion: a prospective observational study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.501 | The effect of early inpatient initiation of Dapagliflozin on the Health-related Quality of Life of patients with heart failure with all range of Ejection Fraction: a Local Registry | Prof. YAN Bryan Ping Yen |
| 2022.164 | A Study on Outcomes of Surgical and Percutaneous Left Atrial Appendage Closure |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.065 | Real World Effectiveness of Evolocumab among Chinese Patients in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2023.362 | A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.162 | A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.502 | Development of Fluorescence Probes and Nanomaterial for Plaque and Thrombosis Imaging in Patients | Prof. YAN Bryan Ping Yen |
| 2022.573 | Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Willingness to Follow Recommendations for Cardiovascular Prevention | Prof. YAN Bryan Ping Yen |
| 2022.335 | Evaluation of the Relationship Between Arterial Stiffness and Coronary Artery Disease by Stroke-Volume-Allocation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.194 | A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.292 | A novel non-invasive radial artery tonometric cardiovascular monitoring device for assessment of vascular aging, subclinical atherosclerosis and cardiovascular risk in the elderly. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.296 | International Survey on Current Status & Future of Drug-Eluting Stents |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.630 | Renal Artery Sympathetic Denervation by Catheter Ablation after Pulmonary Vein Isolation (PVI) for Persistent Atrial Fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.401 | BIOTRONIKS - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris - Registry: BIOSOLVE-IV | Dr. YAN Bryan Ping Yen |
| 2016.623 | Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong | Dr. YAN Bryan Ping Yen |
| 2016.456 | Diagnostic Accuracy and Incremental Prognostic Value of Exercise MCG in Patients at Risk of Coronary Artery Disease |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.291 | Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2015.297 | Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.381 | Multinational Abluminal Sirolimus Coated BiO-Engineered StenT – The MASCOT Post Marketing Registry | Dr. YAN Bryan Ping Yen |
| 2014.603 | HK-GP AF Screening & Education Program | Prof. YAN Bryan Ping Yen |
| 2015.302 | ASTRI Wireless ECG Module Public Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.490 | Development of personalized medicine using Prenetics iGenes pharmacogenomic panel to predict individual responses to cardiovascular drugs |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.258 | A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo | Prof. YAN Bryan Ping Yen |
| 2016.509 | Hong Kong Percutaneous Coronary Intervention Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.003 | Implantation of the Venus P-ValveTM in the Pulmonic Position in Patients with Native Outflow Tracts |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.301 | Effects of Cardiovascular Autonomic Nervous System Activities on BP/ECG/PPG/Respiratory Related Physiological Features, Validation of Improved PTT-based Cuffless BP Estimation with IEEE 1708 Standard, and Measurement of Respiratory Rate with a Novel Method |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.550 | Validation of Camera-based Measurement of Finger & Facial Photoplethysmographic Signal for Heart Rate and Arrhythmias Detection |
Prof. YAN Bryan Ping Yen 甄秉言 |
Page 19 of 289.